Allan RK, Mok D, Ward BK, Ratajczak T
The primary outcomes of these trials were 3-point major adverse cardiovascular event (3-MACE) and the studies have together provided a wealth of data that, amongst others, have changed clinical guidelines
The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight
Numbness or Tingling in Extremities: Some individuals may experience a sensation of pins and needles in their hands and feet
In three separate trials, more than 80 women in the 20th week of pregnancy took a L-carnitine supplement in different doses until giving birth